Dr. Kunj Patel, MD, MSc

General Statement of Disclosure:

OWNERSHIP/PARTNERSHIP/PRINCIPAL: SafeBeat Rx: startup company (preclinical research submitted to NIH. $0 non-public equity)(NONE)

View Full Disclosure